Polyethylenimine-mediated cochlear gene transfer in guinea pigs

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 8, 2008, Pages 884-891

  Tan, Brian Tiong Gee ^a,b   Foong, Kok Heng ^c   Lee, Myranda Mui Gek ^a   Ruan, Runsheng ^a,c  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; NITROGEN; PHOSPHATE; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; COCHLEA; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSMOTIC PUMP; REPORTER GENE; SURGICAL TECHNIQUE;

ANIMALS; BASILAR MEMBRANE; COCHLEA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; GUINEA PIGS; MALE; MICROSCOPY, CONFOCAL; POLYETHYLENEIMINE; TRANSFECTION;

EID: 49949094165     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.8.884     Document Type: Article

References (46)

1. Lehrman S. Virus treatment questioned after gene therapy death. Nature. 1999; 401(6753):517-518.
2. Couzin J, Kaiser J. Gene therapy: as Gelsinger case ends, gene therapy suffers another blow. Science. 2005;307(5712):1028.
3. Staecker H, Li D, O'Malley BW Jr, Van De Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol. 2001;121(2):157-163.
4. Jero J, Tseng CJ, Mhatre AN, Lalwani AK. A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear Res. 2001;151(1-2):106-114.
5. Jero J, Mhatre AN, Tseng CJ, et al. Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther. 2001;12(5):539-548.
6. Wareing M, Mhatre AN, Pettis R, et al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res. 1999;128(1-2):61-69.
7. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine- mediated DNA transfection and the proton sponge hypothesis. J Gene Med. 2005;7(5):657-663.
8. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995;92(16):7297-7301.
9. Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther. 2001;3(2):178-182.
10. Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm. 2005;60(2):247-266.
11. Morrison A, Hodgetts C, Gossler A, Hrabé de Angelis M, Lewis J. Expression of Delta1 and Serrate1 (Jagged1) in the mouse inner ear. Mech Dev. 1999;84(1-2):169-172.
12. Coppens AG, Kiss R, Heizmann CW, Schafer BW, Poncelet L. Immunolocalization of the calcium binding S100A1, S100A5 and S100A6 proteins in the dog cochlea during postnatal development. Brain Res Dev Brain Res. 2001;126(2):191-199.
13. Zhao HB. Long-term natural culture of cochlear sensory epithelia of guinea pigs. Neurosci Lett. 2001;315(1-2):73-76.
14. Hurley PA, Clarke M, Crook JM, Wise AK, Shepherd RK. Cochlear immunochemistry: a new technique based on gelatin embedding. J Neurosci Methods. 2003;129(1):81-86.
15. Raphael Y, Frisancho JC, Roessler BJ. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett. 1996;207(2):137-141.
16. Cooper LB, Chan DK, Roediger FC, et al. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol Neurotol. 2006;27(4):484-490.
17. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol. 2004;9(3):135-143.
18. Hakuba N, Watabe K, Hyodo J, et al. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther. 2003;10(5):426-433.
19. Kawamoto K, Sha SH, Minoda R, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther. 2004;9(2):173-181.
20. Kawamoto K, Yagi M, Stöver T, Kanzaki S, Raphael Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther. 2003;7(4):484-492.
21. Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11(3):271-276.
22. Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci. 2003;23(11):4395-4400.
23. Staecker H, Praetorius M, Baker K, Brough DE. Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer. Otol Neurotol. 2007;28(2):223-231.
24. Bedrosian JC, Gratton MA, Brigande JV, Tang W, Landau J, Bennett J. In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function. Mol Ther. 2006;14(3):328-335.
25. Stone IM, Lurie DI, Kelley MW, Poulsen DJ. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol Ther. 2005;11(6):843-848.
26. Stöver T, Yagi M, Raphael Y. Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res. 1999;136(1-2):124-130.
27. Lalwani AK, Jero J, Mhatre AN. Current issues in cochlear gene transfer. Audiol Neurootol. 2002;7(3):146-151.
28. Han JJ, Mhatre AN, Wareing M, et al. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther. 1999;10(11):1867-1873.
29. Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther. 2000;7(12):1046-1054.
30. Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y. Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther. 1999;10(5):769-774.
31. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear Res. 2002;173(1-2):187-197.
32. Brunot C, Ponsonnet L, Lagneau C, Farge P, Picart C, Grosgogeat B. Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films. Biomaterials. 2007;28(4):632-640.
33. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther. 2005;11(6):990-995.
34. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res. 1999;134(1-2):1-8.
35. Carvalho GJ, Lalwani AK. The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. Am J Otol. 1999;20(1):87-90.
36. Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther. 2001;12(7):773-781.
37. Luebke AE, Steiger JD, Hodges BL, Amalfitano A. A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther. 2001;8(10):789-794.
38. Merdan T, Kunath K, Petersen H, et al. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dosedependent manner after intravenous injection into mice. Bioconjug Chem. 2005;16(4):785-792.
39. Remaut K, Lucas B, Raemdonck K, Braeckmans K, Demeester J, De Smedt SC. Protection of oligonucleotides against enzymatic degradation by pegylated and nonpegylated branched polyethyleneimine. Biomacromolecules. 2007;8(4):1333-1340.
40. Kunath K, Merdan T, Hegener O, Haberlein H, Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med. 2003;5(7):588-599.
41. Merdan T, Callahan J, Petersen H, et al. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem. 2003;14(5):989-996.
42. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycolpolyethylenimine/DNA complexes. J Control Release. 2003;91(1-2):173-181.
43. Tseng WC, Jong CM. Improved stability of polycationic vector by dextrangrafted branched polyethylenimine. Biomacromolecules. 2003;4(5):1277-1284.
44. Moret I, Esteban Peris J, Guillem VM, et al. Stability of PEI-DNA and DOTAPDNA complexes: effect of alkaline pH, heparin and serum. J Control Release. 2001;76(1-2):169-181.
45. Twaites BR, de las Heras Alarcon C, Cunliffe D, et al. Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J Control Release. 2004;97(3):551-566.
46. Yokoyama M. Gene delivery using temperature-responsive polymeric carriers. Drug Discov Today. 2002;7(7):426-432.